HAEMONETICS CORP MASS - NOTE 3/0

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Debt / NOTE 3/0
Market price (% of par)
83.13%
Total 13F principal
$438,307,098
Principal change
-$6,326,857
Total reported market value
$364,276,052
Number of holders
48
Value change
-$4,237,742
Number of buys
13
Number of sells
18

Institutional Holders of HAEMONETICS CORP MASS - NOTE 3/0 as of Q4 2022

As of 31 Dec 2022 HAEMONETICS CORP MASS - NOTE 3/0 had 48 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of $438,307,098 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included ADVENT CAPITAL MANAGEMENT /DE/, FRANKLIN RESOURCES INC, Kohlberg Kravis Roberts & Co. L.P., AVIVA PLC, OAKTREE CAPITAL MANAGEMENT LP, Linden Advisors LP, Aequim Alternative Investments LP, MACKAY SHIELDS LLC, OSTERWEIS CAPITAL MANAGEMENT INC, and DeepCurrents Investment Group LLC.
This table shows 48 bond principal holders of the security as of 31 Dec 2022.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.